Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.810
-0.590 (-10.93%)
Mar 31, 2025, 4:00 PM EDT - Market closed

Radiopharm Theranostics Revenue

Radiopharm Theranostics had revenue of 2.44M AUD in the half year ending December 31, 2024, a decrease of -42.81%. This brings the company's revenue in the last twelve months to 330.63K, down -94.50% year-over-year. In the fiscal year ending June 30, 2024, Radiopharm Theranostics had annual revenue of 1.96M, down -68.46%.

Revenue (ttm)
330.63K AUD
Revenue Growth
-94.50%
P/S Ratio
192.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
39.30M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20241.96M-4.25M-68.46%
Jun 30, 20236.21M--
Jun 30, 2022---
Jun 30, 2021---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition